[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Funding Opportunity: IC Impacts/Portable Diagnostics and Analyzers

For your information, the message from IC-IMPACTS below is being forwarded to nserc-list members.  

SFU Simon Fraser University 
Office of Research Services (ORS) 
Discovery 2 
t: 778-782-6816
f: 778-782-3477


"SFU - Engaging the World"

IC-IMPACTS is publicizing a new Joint Call for Research with India supported by IC-IMPACTS and the Department of Biotechnology (DBT) India. 

This call is in the area of Portable Diagnostics and Analyzers.  A synopsis of the focus for the Call is provided below. Full details and application formal and submission portal can be found on our website at : http://ic-impacts.com/dbt/.  We would appreciate you forwarding this to any interested researchers at your institutions. The deadline for applications is March 7, 2016.

IC-IMPACTS – DBT (India) Call for Proposals in Portable Diagnostics and Analyzers:

There is a need for portable assays which bring the high quality diagnostics associated with a central lab to the patient. This call for proposals will focus on automated assays which can multiplex tests for a range of diseases into a simple portable test. Tests should be based on easily collected sample types such as a finger stick of blood, or a small sample of saliva or urine.

A complete blood count measures multiple components and features within a blood sample and is a routine test to monitor overall health, as part of a medical diagnosis or to monitor treatment. In the developed world a CBC is a routine part of an annual medical exam. In emergency room admissions more than 50% of patients have some type of blood work carried out. White blood cell counts can give an indication of bacterial vs viral infection, and red blood cell counts can give an indication of anemia. Despite the real benefits of the CBC the instrumentation needed requires central laboratory facilities, trained technical support and is time consuming. This makes it unsuitable for deployment in a rural or remote setting.

Other bodily fluids, such as saliva can also be extremely effective in disease diagnosis. Saliva contains a number of biomarkers which make it particularly useful and amenable for multiplexed assays that can be used in point-­of-­care devices. Saliva has been well known to for indications of oral infections and oral cancers, but recent discoveries have led to its application in a growing number of areas including detection of antibodies to the Human Immunodeficiency Virus (HIV) and systemic diseases. Many interesting projects are unfolding exploring the ability of oral biomarkers now for chronic obstructive pulmonary disease, cystic fibrosis, TB, and Malaria, for instance. The collaboration between nanotechnology, microfluidic techniques and oral biology is yielding exciting and dynamic results and has the potential for major breakthroughs in providing portable and rapid diagnostics to improve care.

We are particularly interested in technologies, which can lead to miniature, portable, and cartridge based diagnostics and analyzers using bodily fluids such as blood, saliva or urine. Of particular interest are portable, field deployable devices and technologies which:

  • Can perform a complete blood count at the point of
  • Differentiate between viral and bacterial infection
  • Provide portable detection system for Dengue, HIV, Hepatitis , Malaria and TB
  • Aid in the detection of systemic disease
  • Monitor the nutritional state of a patient (vitamin D, ferritin etc)
  • Require low sample volume for application in infant health care
  • Bring together multiple disciplines for innovative results

The Joint Call for Collaborative Research Innovation Projects in the area of “Portable Diagnostics and Analyzers” will support collaborative research projects focused on the development and evaluation of new diagnostics and analyzers in each of the following areas:

  • Infectious Diseases
  • Maternal and Infant Health
  • Nutritional Deficiency
  • Interdisciplinary Approaches and Platform Technologies
For further information, contact:
Sue Roppel
Chief Operating Officer & Network Manager
IC-IMPACTS Centres of Excellence
Room 305, 6190 Agronomy Road
The University of British Columbia
Vancouver, B.C.  V6T 1Z3
Telephone:  604.827.1522
email: roppel@ic-impacts.com
website: http://www.ic-impacts.com